These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1784587)

  • 21. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of exogenous CCK-8 on the acquisition and expression of morphine-induced CPP.
    Wen D; Cong B; Ma C; Yang S; Yu H; Ni Z; Li S
    Neurosci Lett; 2012 Feb; 510(1):24-8. PubMed ID: 22245440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hippocampal serotonin mediates hypoactivity in dietarily obese hamsters: a possible manifestation of aging?
    Borer KT; Bonna R; Kielb M
    Pharmacol Biochem Behav; 1988 Dec; 31(4):885-92. PubMed ID: 3252281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraperitoneal injection of cholecystokinin elicits sleep in rabbits.
    Kapás L; Obál F; Opp MR; Johannsen L; Krueger JM
    Physiol Behav; 1991 Dec; 50(6):1241-4. PubMed ID: 1798781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supraspinal FMRFamide antagonizes morphine-induced horizontal, but not vertical, locomotor activity.
    Raffa RB
    Peptides; 1989; 10(2):403-6. PubMed ID: 2755878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential interaction of cholecystokinin with morphine and phencyclidine: effects on operant behavior in pigeons.
    Winsauer PJ; Thompson DM
    Pharmacol Biochem Behav; 1992 Jan; 41(1):83-90. PubMed ID: 1539083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of morphine-induced in vivo release of cholecystokinin in rat dorsal horn: effects of ion channel blockers.
    Gustafsson H; Afrah A; Brodin E; Stiller CO
    J Neurochem; 1999 Sep; 73(3):1145-54. PubMed ID: 10461906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
    Pu SF; Han JS
    Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral evidence for cholecystokinin-opiate interactions in neonatal rats.
    Weller A; Blass EM
    Am J Physiol; 1988 Dec; 255(6 Pt 2):R901-7. PubMed ID: 3202224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential release of cholecystokinin by morphine in rat spinal cord.
    de Araujo Lucas G; Alster P; Brodin E; Wiesenfeld-Hallin Z
    Neurosci Lett; 1998 Mar; 245(1):13-6. PubMed ID: 9596344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260.
    O'Neill MF; Dourish CT; Iversen SD
    Eur J Pharmacol; 1991 Feb; 193(2):203-8. PubMed ID: 2050197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of tifluadom on cholecystokinin-induced antinociception.
    Gericke M; Morgenstern R; Ott T
    Eur J Pharmacol; 1990 May; 180(1):187-90. PubMed ID: 2365002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prior and delayed applications of dizocilpine or ethanol alter locomotor sensitization to morphine.
    Kosten TA; Bombace JC
    Brain Res; 2000 Sep; 878(1-2):20-31. PubMed ID: 10996133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphine tolerance and sensitization in the hamster.
    Schnur P
    Pharmacol Biochem Behav; 1985 Jan; 22(1):157-8. PubMed ID: 3975241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of climbing and mossy fiber input to mouse cerebellar Purkinje cells by cholecystokinin.
    Wood PL; Steel DJ; Kim HS; Petrack B; Altar CA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):58-62. PubMed ID: 2826774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An assessment of the interaction between cholecystokinin and the opiates within a drug discrimination procedure.
    Melton PM; Riley AL
    Pharmacol Biochem Behav; 1993 Sep; 46(1):237-42. PubMed ID: 8255917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in nucleus accumbens of the rat via the CCK-B receptor.
    Pu SF; Zhuang HX; Han JS
    Brain Res; 1994 Sep; 657(1-2):159-64. PubMed ID: 7820614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cataleptogenic and anticataleptic activity produced by cholecystokinin octapeptides in mice.
    Kádár T; Borda L; Penke B; Kovács K; Telegdy G
    Neuropeptides; 1985 Jun; 6(3):259-68. PubMed ID: 4040614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of chronic morphine on biliary tract responses to cholecystokinin-octapeptide in female guinea pigs.
    Malave A; Yim GK
    Life Sci; 1993; 52(8):695-700. PubMed ID: 8445999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cholecystokinin on pancreatic carcinogenesis in the hamster model.
    Pour PM; Lawson T; Helgeson S; Donnelly T; Stepan K
    Carcinogenesis; 1988 Apr; 9(4):597-601. PubMed ID: 2833367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.